TABLE 2.

Case Characteristics During ¹⁷⁷Lu-PSMA-I&T Treatment

	Case 1		Case 2
Characteristic	Dose 1	Dose 2	Dose 1	Dose 2
PSA (0.3–6.5 μg/L)	540	31	4,960	723
Hemoglobin (128–175 g/L)	117	104	89	82
Platelets (150–450 × 10⁹/L)	97	150	241	108
Alkaline phosphatase (35–110 U/L)	195	2,049	311	240
Estimated glomerular filtration rate (>60 mL/min/1.73 m²)	>90	>90	49	73
Parathyroid hormone (1.6–7.2 pmol/L)	NA	27.7	NA	42
25-hydroxyvitamin D₃ (50–140 nmol/L)	88	55	NA	87
Corrected calcium (2.15–2.55 mmol/L)	2.29	1.54	2.11	1.68